Atara Biotherapeutics (ATRA) Capital Expenditures (2014 - 2024)
Atara Biotherapeutics (ATRA) reported Capital Expenditures of $90000.0 for Q4 2024, down 19.64% on a YoY basis from $112000.0 in Q1 2024, and up 210.34% quarter-over-quarter from $29000.0 in Q2 2024.
Atara Biotherapeutics (ATRA) Capital Expenditures (2014 - 2024) Analysis & Trends
Atara Biotherapeutics has reported Capital Expenditures for 11 years, with the latest figure at $90000.0 in Q4 2024.
- For the quarter ending Q4 2024, Capital Expenditures fell 19.64% year-over-year to $90000.0; the trailing twelve-month figure through Sep 2025 stood at $90000.0 (down 66.42% YoY), and the FY2024 full-year result was $246000.0, up 86.36% from the prior year.
- Capital Expenditures for Q4 2024 stood at $90000.0, up from $29000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $8.7 million in Q4 2021, with the low at -$3.6 million in Q4 2020.
- Historically, Capital Expenditures has averaged $597105.3 across 5 years, with a median of $112000.0 in 2023.
- Annual changes were most pronounced in 2020 — Capital Expenditures surged 1175.65% — and 2021, when it slumped 577.14%.
- Atara Biotherapeutics' Capital Expenditures stood at -$3.6 million in 2020, then soared by 343.22% to $8.7 million in 2021, then sank by 99.7% to $26000.0 in 2022, then soared by 330.77% to $112000.0 in 2023, then declined by 19.64% to $90000.0 in 2024.
- The last three Capital Expenditures figures came in at $90000.0 (Q4 2024), $29000.0 (Q2 2024), and $127000.0 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -63,220.27 |
| 10 | Atara Biotherapeutics | 134.61 Mn | 126.21 Mn | 392,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 90,000.00 |
| Dec 31, 2024 | 90,000.00 |
| Jun 30, 2024 | 29,000.00 |
| Jun 30, 2024 | 29,000.00 |
| Mar 31, 2024 | 127,000.00 |
| Mar 31, 2024 | 127,000.00 |
| Dec 31, 2023 | 112,000.00 |
| Dec 31, 2023 | 112,000.00 |
| Sep 30, 2023 | -88,000.00 |
| Sep 30, 2023 | -88,000.00 |
| Jun 30, 2023 | -291,000.00 |
| Jun 30, 2023 | -291,000.00 |
| Mar 31, 2023 | 399,000.00 |
| Mar 31, 2023 | 399,000.00 |
| Dec 31, 2022 | 26,000.00 |
| Dec 31, 2022 | 26,000.00 |
| Sep 30, 2022 | -97,000.00 |
| Sep 30, 2022 | -97,000.00 |
| Jun 30, 2022 | -1.06 Mn |
| Jun 30, 2022 | -1.06 Mn |